Application of precision medicine: can molecular risk stratification provide new management options for low stage endometrioid ovarian carcinoma?

P Krämer; A Talhouk; T Bosse; F Heitz; S Prader; N Singh; F Kommoss; B Krämer; A Hartkopf; S Brucker; J McAlpine; M Koebel; M Anglesio; S Kommoss

doi:10.1136/ijgc-2019-ESGO.41

Article info

Young Investigators Oral Presentations (ENYGO Session)

Application of precision medicine: can molecular risk stratification provide new management options for low stage endometrioid ovarian carcinoma?

Authors

P Krämer Department of Women’s Health, Tuebingen University Hospital, Tuebingen, Germany PubMed articles Google scholar articles
A Talhouk Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, BC, Canada PubMed articles Google scholar articles
T Bosse Department of Pathology, Leiden University Medical Centre, Leiden, The Netherlands PubMed articles Google scholar articles
F Heitz Department of Gynecology and Gynecologic Oncology, Kliniken Essen Mitte, Essen Department of Gynecology and Gynecologic Oncology, Charité Campus Virchow-Klinikum, Berlin, Germany PubMed articles Google scholar articles
S Prader Department of Gynecology and Gynecologic Oncology, Kliniken Essen Mitte, Essen PubMed articles Google scholar articles
N Singh Department of Pathology, Barts Health NHS Trust, London, UK PubMed articles Google scholar articles
F Kommoss Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany PubMed articles Google scholar articles
B Krämer Department of Women’s Health, Tuebingen University Hospital, Tuebingen, Germany PubMed articles Google scholar articles
A Hartkopf Department of Women’s Health, Tuebingen University Hospital, Tuebingen, Germany PubMed articles Google scholar articles
S Brucker Department of Women’s Health, Tuebingen University Hospital, Tuebingen, Germany PubMed articles Google scholar articles
J McAlpine Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, BC, Canada Department of Molecular Oncology, BC Cancer Research Centre, Vancouver, BC PubMed articles Google scholar articles
M Koebel Department of Pathology and Laboratory Medicine, University of Calgary and Calgary Laboratory Services, Calgary, AB PubMed articles Google scholar articles
M Anglesio Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, BC, Canada Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada PubMed articles Google scholar articles
S Kommoss Department of Women’s Health, Tuebingen University Hospital, Tuebingen, Germany PubMed articles Google scholar articles

Citation

Krämer P, Talhouk A, Bosse T, et al

Application of precision medicine: can molecular risk stratification provide new management options for low stage endometrioid ovarian carcinoma?

International Journal of Gynecologic Cancer 2019;29:A37.

Publication history

First published November 1, 2019.

Online issue publication

March 03, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password